top of page
Search
All Posts
What are MPNs?
Diagnosed with MPN?
Living with MPNs
Women
Teens & Children
Events
MPN News
MPN Stories
Clinical Trials
Worldwide Day
Wellbeing
Dietary Main Course
You Tube Channel
Dietary Breakfast
Webinars
Global MPN Symposium
Upcoming videos for the MPN Educational Roundtables 2024!
MPN NEWS
Peter Löffelhardt
Mar 5, 2024
Bridging Borders: Interview with MorphoSys
MPN NEWS
Peter Löffelhardt
Feb 6, 2024
Novartis to Strengthen Oncology Pipeline with Agreement to Acquire MorphoSys AG, Including Late-Stage BET Inhibitor Pelabresib for Myelofibrosis (MF)
MPN NEWS
Peter Löffelhardt
Feb 6, 2024
Save the Date: May 24th - 26th, 2024 I 4th MPN Spring Symposium - A Hybrid Experience from Barcelona!
EVENTS
Peter Löffelhardt
Feb 6, 2024
The potential of Tasquinimod in the treatment of advanced Myeloproliferative Neoplasms (MPNs): A look into the future
MPN NEWS
Peter Löffelhardt
Feb 5, 2024
Strategies for Managing Anxiety in MPN Patients
LIVING WITH MPNS
Peter Löffelhardt
Feb 5, 2024
World Cancer Day and MPNs
MPN NEWS
Peter Löffelhardt
Feb 2, 2024
Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset
MPN NEWS
Peter Löffelhardt
Feb 1, 2024
31
32
33
34
35
Home
bottom of page